Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?Expert review of neurotherapeutics · 2026-07-23No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03Provider perspectives on challenges in treatment during psychedelic therapy.Psychopharmacology · 2026-07-01Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-01Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-29Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29Human brain changes after first psilocybin useNature Communications · 2026-05-05Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronseLife · 2026-03-27Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-03-20Psilocybin effects on brain functional connectivity: a systematic review of fMRI studiesDiscover Mental Health · 2026-03-19Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-01The effect of psilocin on neurotransmitters release in the claustrum and on rat behaviorPharmacological Reports · 2026-02-01Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.Journal of psychoactive drugs · 2026-01-01Microdosing Psychedelics to Improve MoodClinicalTrials.gov · 2025-12-30The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.American journal of psychotherapy · 2025-12-15A causal pluralist theory of the interaction of substance, set and setting in psychedelic experiencePhilosophical Psychology · 2025-11-30Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive DisorderClinicalTrials.gov · 2025-11-26Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.Schizophrenia bulletin · 2025-10-06Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS pharmacology & translational science · 2025-06-13Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.Neuropharmacology · 2025-05-01Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-29Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.Translational psychiatry · 2025-03-25LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-13Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.The Journal of clinical psychiatry · 2025-02-05The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.International journal of mental health nursing · 2025-02-01Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.Psychedelics · 2025-01-01Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024-12-02The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.Journal of medicinal chemistry · 2024-05-09Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyClinicalTrials.gov · 2024-04-25The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-22Psilocybin induces dose-dependent changes in functional network organization in rat cortex.bioRxiv: the preprint server for biology · 2024-02-15Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.American journal of therapeutics · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.American journal of therapeutics · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-26Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-26The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-04Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.Journal of psychiatric research · 2023-05-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-10The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.Journal of psychopharmacology (Oxford, England) · 2023-01-01Classic psychedelics do not affect T cell and monocyte immune responses.Frontiers in psychiatry · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Psychedelics, epilepsy, and seizures: a review.Frontiers in pharmacology · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug testing and analysis · 2022-08-01A systematic literature review of clinical trials and therapeutic applications of ibogaine.Journal of substance abuse treatment · 2022-07-01Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.Psychopharmacology · 2022-06-01The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01Psychedelic use predicts objective knowledge about climate change via increases in nature relatednessDrug Science Policy and Law · 2022-01-01Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PloS one · 2022-01-01Lower-dose psycholytic therapy - A neglected approach.Frontiers in psychiatry · 2022-01-01P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or PanaceaPsychiatric News · 2021-11-29New Insights Into the Clinical and Nonclinical Effects of Psychedelic SubstancesEuropean Psychologist · 2021-09-17Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experienceEuropean Neuropsychopharmacology · 2021-09-01New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPsyArXiv · 2021-05-05New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPsyArXiv · 2021-05-05Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of natural products · 2021-04-23Have Norwegians tried psilocybin, and do they accept it as a medicine?Journal of Psychedelic Studies · 2021-04-16Investigation of the Structure-Activity Relationships of Psilocybin Analogues.ACS pharmacology & translational science · 2021-04-09Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Dose-response relationships of psilocybin-induced subjective experiences in humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-05Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01DARK Classics in Chemical Neuroscience: NBOMes.ACS chemical neuroscience · 2020-12-02P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-11-01Reviewing the Potential of Psychedelics for the Treatment of PTSD.The international journal of neuropsychopharmacology · 2020-06-24Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology · 2020-05-01Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.Journal of natural products · 2020-02-28Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.Proceedings of the National Academy of Sciences of the United States of America · 2020-02-04Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leadersBMJ · 2020-01-31Hallucinogens and Their Therapeutic Use: A Literature Review.Journal of psychiatric practice · 2019-09-01Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.Health SA = SA Gesondheid · 2018-12-31DARK Classics in Chemical Neuroscience: Psilocybin.ACS chemical neuroscience · 2018-10-17Effect of Hallucinogens on Unconditioned Behavior.Current topics in behavioral neurosciences · 2018-01-01Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.Journal of psychopharmacology (Oxford, England) · 2017-08-01[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.Behavioural brain research · 2015-01-15Serotonergic hallucinogens as translational models relevant to schizophrenia.The international journal of neuropsychopharmacology · 2013-11-01Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.Experimental brain research · 2013-08-01Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.Journal of psychopharmacology (Oxford, England) · 2011-11-01Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Neuropharmacology · 2011-09-01Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.Archives of general psychiatry · 2011-01-01Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-07-01The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case seriesCephalalgia · 2010-03-26Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of psychopharmacology (Oxford, England) · 2007-05-01Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-11-01Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosisPharmacopsychiatry · 2005-09-01The pharmacology of psilocybin.Addiction biology · 2002-10-01Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.Neuropsychobiology · 2002-01-01Detection of psilocin in body fluidsForensic Science International · 2000-09-01Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.Behavioural pharmacology · 1998-11-01529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-09-01A Novel Extraction Procedure for Psilocybin and Psilocin Determination in Mushroom SamplesPlanta Medica · 1990-06-01Psilocybin in Fruchtkörpern vonInocybe aeruginascensPlanta Medica · 1986-04-01Psilocybin intoxication.The British journal of psychiatry: the journal of mental science · 1980-09-01ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLESCanadian Journal of Chemistry · 1963-09-30